Chapter 12

Oxidative stress in osteoarticular diseases

María José Alcaraz

María José Alcaraz

Department of Pharmacology and IDM, University of Valencia, Valencia, Spain

Search for more papers by this author
Sergio Portal-Núñez

Sergio Portal-Núñez

Bone and Mineral Metabolism Laboratory, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz and UAM, Madrid, Spain

Search for more papers by this author
Juan A. Ardura

Juan A. Ardura

Bone and Mineral Metabolism Laboratory, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz and UAM, Madrid, Spain

Search for more papers by this author
Pedro Esbrit

Pedro Esbrit

Bone and Mineral Metabolism Laboratory, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz and UAM, Madrid, Spain

Search for more papers by this author
First published: 29 January 2016

Summary

A wide range of evidence supports the contribution of reactive oxygen species (ROS) and reactive nitrogen species (RNS) to osteoarticular disorders. An imbalance between the production of ROS and/or RNS and the activity of the antioxidant defense systems result in oxidative stress, which contributes to rheumatoid arthritis (RA) pathology. The functioning of immune cells is influenced by alterations in the intracellular redox balance. Synovial hyperplasia and chronic inflammation are associated with a lack of apoptosis of immune cells and synovial fibroblasts, which depends on the activation of nuclear factor-kappa B (NF-KB) and other signaling pathways inducing the expression of antiapoptotic molecules. Degradation of joint components in osteoarthritis (OA) is thought to be largely elicited by mechanical stress and proinflammatory cytokines inducing ROS production and inducible nitric oxide synthase (iNOS) expression. Accumulated evidence in recent years indicates that oxidative stress is a pivotal pathogenetic culprit in aging and other osteoporosis-related conditions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.